Ryan M. Thomas, MD

Associate Professor, Department of Surgery, Division of Surgical Oncology

Ryan M. Thomas, MD, earned his medical degree from Loyola University Chicago and completed his surgical residency at the University of Cincinnati. For two years during his residency, he was a National Institutes of Health T32 research fellow, studying the role of the RON tyrosine kinase receptor signaling that leads to pancreatic cancer progression. Following residency, he completed a two-year fellowship in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center, which included an additional laboratory year studying chemotherapy delivery and resistance in pancreatic cancer. He is dual boarded in General Surgery and Complex General Surgical Oncology.

Thomas currently serves on the UF Promotion and Tenure Committee and is the Chairman of the Scientific Review and Monitoring Committee for the UF Health Cancer Center as well as the director of the UF Health Cancer Center Microbiome Biorepository. He is the principal investigator on several grants investigating the role of the microbiome in pancreatic carcinogenesis within his laboratory at UF Health.

Education
1996-1999  B.S., Cum Laude, John Carroll University, Cleveland, OH
1999-2003  M.D., Loyola University of Chicago Stritch School of Medicine, Maywood, IL

Postdoctoral Training
2003-2009  Resident, Department of General Surgery, University of Cincinnati College of Medicine, Cincinnati, OH
2005-2007  T32 NIH Research Fellow, Department of General Surgery, University of Cincinnati College of Medicine, Cincinnati, OH
2009-2010  Chief Resident, Department of General Surgery, University of Cincinnati College of Medicine, Cincinnati, OH
2010-2013  Fellow, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
2012-2013  Administrative Fellow, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston,TX

Research Interests:
The role of the microbiome in pancreatic carcinogenesis
Molecular mechanisms of chemoresistance in pancreatic cancer
Tumorigenesis of pancreatic cancer